Skip to main content
. 2019 Mar 20;20(6):1417. doi: 10.3390/ijms20061417

Figure 2.

Figure 2

Cytotoxicity of the peptides against human red blood cells (hRBCs) (A), RAW 264.7 (B), and HEK293T (C). Results were given as the mean ± standard deviation (SD) of three independent trials. Differences between groups exposed to the same concentration were determined by one-way ANOVA followed by Turkey’s post-hoc analysis (n = 3). The values with different superscripts (a, b, c, d) indicate a significant difference (p < 0.05).